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Extracts from Letharia vulpina, Umbilicaria americana, Cladina subtenuis, 
Xanthoparmelia cumberlandia, Rimelia reticulata, and Parmotrema austrosinense 
were used to study their electrophysiological effects on rat heart ventricular tissue. 
Additionally, solutions of four purified lichen metabolites -—vulpinic acid, usnic acid, 
stictic acid, and atranorin -— were studied in the same manner. The action potential 
duration at 50% and 90% of repolarization was significantly reduced by two of the 
extracts and metabolites, those containing vulpinic acid and usnic acid and the 
purified forms of those compounds. A positive relationship between the effects of 
extracts and purified compounds was exhibited. These data suggest that the active 
metabolites may depress inward calcium current or enhance outward potassium 
currents. However, when single, dissociated rat myocytes were exposed to vulpinic 
acid, activation of an ATP-sensitive potassium channel was observed, and this was 
blocked with glibenclamide, a specific blocker of that channel. This ATP-sensitive 
potassium channel created an overlapping current which made it appear that an 
inward calcium current or outward repolarizing currents were affected, when in fact 
they were not.
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INTRODUCTION
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Several lichen species have been utilized as medicines, curatives, and 
folk remedies since the Middle Ages. Certain American Indians and Chinese 
herbalists have used them as expectorants. Some forms are being sold in parts 
of Europe today to treat a variety of ailments such as diabetes, inflammation of 
nose or throat membranes, or lung diseases, and in other parts of the world, eg. 
India and South America, they have been popular as treatments for liver 
diseases and for a number of other purposes. Evernia vulpina (Letharia 
vulpina) has been used as a poison for wolves (Hale 1983; Fink 1910).
In the last three decades several lichen-forming fungi have been 
investigated for the pharmacological activity of their primary and secondary 
metabolites. Some of these compounds appear to have useful effects including 
antibiotic activity (Varita 1973), antiviral and antitumor activities (Fukuoka et al. 
1968; Hirabayashi et al. 1989), and anti-inflammatory effects (Otsuka et al.
1972; Shibuya et al. 1983). The possibility that more activities of these 
compounds will be discovered and utilized is likely, and may become an 
important part of the bio-pharmaceutical industry (Yamamoto et al. 1993).
Soderberg, in the early 1950’s performed a series of investigations to 
determine the in vivo effects of usnic and vulpinic acids on anesthetized cats.
He showed that usnic acid increased respiration rate and amplitude, produced 
a transient fall in blood pressure, and increased body temperature. A dose- 
dependent relationship between usnic acid and a rise in blood glucose level 
was also observed. At concentrations above 10 mg/kg, lethality occurred and 
muscular rigor was observed almost immediately after death. These effects 
were similar to those produced by dinitrophenols (Soderberg 1953). The use of
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vulpinic acid in cats resulted in a similar hyperventilation and hypotension, but it 
had an opposite effect on blood glucose regulation. In some experiments 
vulpinic acid normalized blood-sugar levels in depancreatized cats (Soderberg 
1954).
A review of published literature over the past thirty years reveals that little 
basic research has been performed on the pharmacological and physiological 
effects of lichen compounds on mammalian systems or on the mechanisms of 
these effects. This study is the first known investigation of the effects of lichen 
products on the electrical properties of ventricular muscle cells.
The purpose of this experiment was twofold: 1.) To investigate the effects of 
several lichen extracts and purified lichen compounds on electrophysiological 
parameters of rat papillary muscle in vitro, and 2.) To determine ionic mech­
anisms of the effects related to a purified lichen metabolite (vulpinic acid) 
utilizing whole-cell patch-clamp techniques; primarily the effects on potassium 
and calcium currents were examined in isolated, single myocytes from rat heart.
MATERIALS AND METHODS
Extract preparation. Extracts from 6 lichen species-Lef/iar/a vulpina (L.) 
Hue, Clad in a subtenuis (des Abb.) Hale & Culb., Umbilicaria americana Poelt & 
T. Nash, Xanthoparmelia cumberlandia (Gyelnik) Hale, Parmotrema 
austrosinense (Zahlbr.) Hale, and Rimelia reticulata (Taylor) Hale & Fletcher-- 
were prepared as follows: 0.5 g of each of the lichens was dispensed into 
seperate test tubes and crushed with a pestle, followed by the addition of 7.5 
mL of acetone to each tube. The tubes were shaken vigorously and then 
stoppered and allowed to stand overnight (approximately 16 hours). By the end
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of this time all insoluble thallus material had settled to the bottom, and the 
acetone was decanted into a clean tube. The tubes were then left unstoppered 
and the acetone was allowed to evaporate in a fume hood. The dissolved 
material was deposited on the side of the tube as the acetone evaporated 
(approx. 72 hours). 7.5 mL of 100% ethanol was then added to each tube and 
shaken vigorously to redissolve the extracted material. For the experiments, the 
extracts were diluted to 0.1% in Tyrodes solution. All lichens used for this study 
were kindly supplied by Dr. Robert Egan, Dept, of Biology, University of 
Nebraska at Omaha. A listing of abbreviations used in the thesis is included in 
Table I.
Pure samples of vulpinic acid (VA), usnic acid (UA), stictic acid (SA), and 
atranorin (At) were obtained from Sigma Chemical Company. Stock solutions 
of 2 mM in 100% ethanol were prepared, and working concentration for all
experiments were 2 pM of the purified compounds. The control solution for all
experiments was 0.1% ethanol in normal Tyrodes solution. The composition of 
this solution was (in mM): NaCI, 127.9; NaH2P0 4 , 0.9; NaHCOa, 20.0; glucose, 
5.5; MgS04, 0.5; KCI, 4.0; and CaCI2, 2.5; pH 7.4.
Thin-layer chromatography. Thin-layer chromatography (Culberson 
1972) was performed on all purified compound solutions to verify their presence 
and on all extracts to ascertain the existence of the desired metabolites. Results 
of the procedure are shown in Table II. Chemical structures of the purified 
compounds are shown in Figure 1 (from Hale 1983).
Electrophysiology. Papillary muscles were isolated from the hearts of 
euthanized laboratory rats (Ratus norvegicus, Sprague Dawley) and pinned to 
the floor of a tissue bath perfused with oxygenated (95% 0 2, 5% C 02) Tyrodes
VA= Vulpinic Acid 
UA= Usnic Acid 
SA= Stictic Acid 
At= Atranorin
RM P= Resting Membrane Potential 
Amp= Action Potential Amplitude
APD= Action Potential Duration 
APDso= Action Potential Duration at 50%  of 
Repolarization 
APDgo= Action Potential Duration at 90%  of 
Repolarization
TABLE I. Abbreviations used in the thesis.
lto= Transient Outward Potassium Current 
lca= L-Type Calcium Current 
•ss= Steady State Current 
lK=Delayed Rectifier Potassium Current 
lN a /C a =  Sodium/Calcium Exchange 
K a t p =  ATP-Sensitive Potassium Current
4-AP= 4-Aminopyridine 
CoCl2= Cobalt Chloride 
V m= Membrane Voltage 
Vmax= Maximum Rate of Rise of the 
Action Potential Upstroke
SPECIES MAJOR METABOLITES
Letharia vulpina vulpinic acid
Cladina subtenuis usnic acid & fumarprotocetraric 
acid
Umbilicaria americana gyrophoric acid
Rimelia reticulata atranorin & lecanoric acid
Parmotrema austrosinense atranorin & salazinic acid
Xanthoparmelia cumberiandia stictic acid, usnic acid, 
& norstictic acid
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Chemical structures and molecular weights of purified lichen 
compounds used in the experiment.
6
solution warmed to 37% C. Isolated tissues were paced with bipolar electrodes 
(Frederick Haer, P6i stimulator) at a frequency of 1 Hz with 3-5 msec duration 
pulses. Transmembrane potentials were recorded (World Precision Instruments 
Model KS 700) with microelectrodes (DC resistance 10-20 Mohms), displayed 
on an oscilloscope (Tektronix Model 5111 A), and photographed with a Polaroid 
camera. After equilibration of the tissue in Tyrodes solution for at least one 
hour, the control solution (0.1% ethanol in Tyrodes) was allowed to superfuse 
the tissue for at least 15 minutes, followed by the extract (0.1% of ethanol- 
resolubolized extract) or purified compound (0.1% of the ethanol solution to 
give a final concentration of 2 pM) for 10-15 minutes before being washed out
with 0.1% ethanol control solution. A photograph of the action potential trace on 
the oscilloscope was made immediately before beginning wash-out. A 
schematic diagram of the experimental set-up is shown in Figure 2 (modified 
from Jalife and Moe 1979).
Isolation of cardiac myocytes. Excised rat hearts were mounted on a 
modified Langendorff perfusion system, and digested using collagenase Type 2 
(Worthington Biochemical) as previously described (Rozanski and Witt 1994, 
1995). Once dissociated, cells are placed in a nominal calcium Tyrodes
solution (-100 pM Ca2+). Calcium is added back to the cells in an incremental
manner by increasing calcium concentration in each of 3 additional washes 
with Tyrodes, ie. the first wash has approximately 0.5 mM, the second wash has 
approximately 0.9 mM and the third wash contains approximately 1.4 mM Ca2+. 
Cells are cultured in Dulbecco’s modified Eagle’s medium plus Ham’s F-12 
(1:1) after the third wash and are incubated at 37% C until used on the same 







FIGURE 2. A schematic of the experimental set-up for recording action 
potentials from rat papillary muscle.
8
mounted on the stage of an inverted microscope and superfused at a rate of 1-2 
mL/min with modified Tyrodes solution containing 0.5 mM CdCl2 to block
residual Ca2+ channels and ethanol at the same concentration as that used with 
the VA solution (for controls) or VA solution itself (for experiments). The 
modified Tyrodes solution contained (in mM): NaCI, 130; KCI, 4.0; MgC^, 1.2; 
CaCl2 , 1.8; n-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES), 5.0; 
glucose, 18; pH 7.4 adjusted with NaOH.
Recording techniques. Ionic currents were recorded using the whole-cell 
configuration of the patch-clamp technique. Borosilicate glass capillaries were 
pulled (Sutter Instruments, Model P-87) to produce an internal tip diameter of 1-
2 pm and filled with pipette solution containing (in mM): KCI, 135; MgCl2 , 3.0; 
HEPES, 10; Na2-ATP, 3.0; EGTA, 10; Na-GTP, 0.5, pH 7.2 adjusted with KOH. 
Filled pipettes with resistances of 2-4 MGi were coupled to a patch-clamp
amplifier (Axopatch 1C, Axon Instruments) and after creation of a gigaohm seal, 
the membrane within the pipette was ruptured. Series resistance was 
compensated at this time and whole-cell capacitance (Cm) derived as the area 
under the capacitative transient divided by the amplitude (-5 mV) of an applied 
test pulse. A computer program (pCIamp, Axon Instruments) controlled 
command potentials and acquired current signals which were filtered at 2 kHz 
using a four-pole low-pass Besel filter. Currents were sampled at 4 kHZ by a 
12-bit resolution analog-digital-converter (Tecmar Labmaster) and stored on the 
hard disk of a 486 computer. All experiments were performed at room 
temperature (22-24% C).
The transient outward K+ current (lt0) was evoked in each cell by 500 ms 
depolarizing pulses to test potentials between -40 and +60 mV (0.2 Hz). The
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holding potential in these experiments was -80 mV and a 100 ms prepulse was 
applied to -60 mV to inactivate the fast Na+ current. At each test pulse the 
amplitude of lt0 was measured as the difference between peak outward current 
and the current level at the end of the depolarizing clamp pulse, referred to in 
this experiment as the steady state. The steady state current (Iss) was 
measured from the same current trace as the difference from the current level at 
the end of the clamp pulse and 0 current level. Data were normalized as 
current densities by dividing measured current amplitude by whole-cell 
capacitance (pA/pF).
The L-type Ca2+ current (lca) was also measured in some cells by 300
ms depolarizing pulses from a holding potential of -40 mV. Currents were 
monitored continuously by repetitive (0.1 Hz) test pulses to 0 mV, and at regular 
intervals current-voltage (l-V) data were recorded by varying the test potential in 
10 mV steps (0.2 Hz) over a range of -30 to +60 mV. For each test pulse the 
amplitude of lca was measured as the difference between the peak inward and 
the current level at the end of the depolarizing clamp pulse. Data for lca were 
also normalized by dividing the measured current amplitude by whole cell 
capacitance.
Patch-clamp experimental protocols. After seal formation on each cell, 
the modified Tyrodes containing CdCl2 and ethanol was allowed to perfuse the 
cell for 15 minutes with recordings made every 5 minutes. The solution was 
then switched to one containing the VA and after a 1-2 minute wash-in, 
recordings were made every five minutes to observe effects.
Measurements. Measurements were made from transmembrane 
recordings as follows (see Figure 3): resting membrane potential (RMP), action
10








FIGURE 3. Illustration of parameters measured for rat action potentials. Action 
potential calibrations are n mV and msec and values in parenthe­
ses are for Vmax- Abbreviations are explained in the text.
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potential amplitude (Amp.), action potential duration at 50% and 90% of 
repolarization (APD50 and APD90), and maximum rate of rise of the action 
potential upstroke (Vmax), as measured from the ouput of an electronic 
differentiator (WPI). Statistical analyses were done with a commercial computer 
program using the paired T-test comparison for control and extract or metabolite 
data.
RESULTS
Effects of lichen extracts and purified compounds. Rat papillary muscles 
were superfused initially with ethanol at various concentrations ranging from 
0.01% to 0.2% in Tyrodes solution for 15 minutes to determine if the solvent had 
direct effects on electrophysiological properties. Ethanol had little effect on 
RMP, amplitude, Vmax, APD50, or APD90 at any of the concentrations tested 
(APD data shown in Figure 4), and ethanol at 0.1% was the control used 
throughout the experiment. Figure 5 summarizes the effects of different extracts 
on ventricular tissue for all measured parameters. These data illustrate that the 
effects on RMP, Amp., and Vmax (excluding Letharia vulpina) were minimal, but 
changes in APD50 and APD90 were more marked. Four of the extracts caused 
shortening, with Letharia vulpina eliciting the greatest shortening, while Rimelia 
reticulata and Umbilicaria americana caused prolongation (since both Rimelia 
reticulata and Parmotrema austrosinense contained atranorin, an average of 
the two were used for the value recorded in Figure 8). The effects of all extracts 
were reversible except for that from Letharia which did not usually wash out 
and was eventually toxic to the cell. The Letharia extract caused significant 
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FIGURE 4. Summary of the effects of lichen extracts on each measured
parameter. Abbreviations are: C-CIadina] L=Letharia, P=Parmot- 
rema; R=Rimelia; U=Umbilicaria', X=XanthoparmeIia. *=p<0.05, 















FIGURE 5. The effects of ethanol at various concentrations on APD50 and 
APDgo-
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significant shortening of both APD’s as well (p<0.05). For all extracts and 
purified compounds the time of onset of effect was usually 4--8 minutes.
The purified compounds caused similar effects as the extracts, as shown 
in Figure 6. RMP, Amp., and Vmax were not significantly altered while APD50 
and APDgo were more profoundly changed. Two of the purified metabolites 
caused significant shortening of APD, with VA having the greatest effects on 
APD50 and APDgo (62.2% and 52.7% of control, respectively; p<0.01), while UA 
also produced large APD50 and APDgo shortening (65.0% and 65.1% 
respectively; p<0.05). Figure 7 shows superimposed action potentials recorded 
from the same cell before and after superfusion with VA.
Relationship of purified compounds and extracts. A positive, qualitative 
relationship between purified compounds and lichen extracts was found as 
shown in Figure 8. An exact concentration of VA contained in the extract from 
Letharia vulpina could not be determined, but spotting densities on 
chromatography plates revealed a concentration of VA in the extracts probably
greater than 2 pM. The APDgo used for this comparison was the best correlative 
parameter, but APD50 also showed a positive relationship between purified 
compounds and extracts (Appendix /). A comparison of Vmax data also showed 
a similar trend, while the other parameters (RMP and Amp.) did not show a 
relationship between the two groups of muscles studied (Appendix //).
Effects of blocking agents. Although the focus of the present study was to 
examine the overall effects of lichen metabolites, some experiments were 
performed with blocking agents to explore possible ionic mechanisms. The use 
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FIGURE 6 . Effects of purified compounds on each measured parameter.
Abbreviations are: UA=usnic acid; VA=vulpinic acid; At=atranorin; 








FIGURE 7. Superimposed action potentials with 2  |iM VA and control (0.1%
ethanol). Calibration value in parentheses is for Vmax.
120 i
I I Purified
VA L UA C At P SA X
FIGURE 8 . Comparison of changes in APDgo in response to extracts and
purified compounds. Abbreviations are the same as for previous 
figures, except P=Parmotrema/Rimelia.
17
prevent further shortening of APD50 when VA was subsequently applied (Figure 
9A). With 1 mM 4-AP, there was no reduction of the effect whereas at 2  and 5 
mM 4-AP, action potential duration was initially prolonged but the usual effect 
of VA was eventually observed after a delay of about 10 minutes.
The use of 3 mM cobalt chloride (CoCy, a blocker of Ca2 + channels, 
however, did prevent further shortening of the APD50 and reduced the 
shortening of APDgo when VA was applied (Figure 9B). This would indicate that 
Ca2+ channels were being influenced by the extracts and purified compounds.
Pretreatment of the tissue with 10 - 7 M Bay K 8644, a Ca2+ channel 
agonist which influences gating characteristics, caused a slight increase in 
APD50 and APDgo as expected. Application of VA in the presence of Bay K 
8644 however, caused nearly identical shortening of APD50 as was observed 
with VA alone (Figure 9C). Possible modification or antagonism of the gating 
characteristics or activation of these channels was evidenced when the tissue 
was treated with VA, washed out, then followed by application of SA. By itself, 
SA has little effect on APD50 and APDgo (105.6 % and 106.3% of control, 
respectively). When the SA followed VA, however, APD50 and APDgo were 
reduced to 36.7% and 40.0% of control, respectively.
When glibenclamide, a blocker of ATP-sensitive K+ channels, was used 
in this study in the presence of VA, APD50 was not shortened, but in fact was
slightly prolonged, and no shortening of APDgo was observed (Fig 9D).
Effects of VA on isolated myocytes. Because VA had the greatest effects 
on APD in the tissue phase of the experiment, VA was chosen for use during 




FIGURE 9. Superimposed action potentials from the same cell with various
channel blocking agents with and without VA. Arrows in all panels 
point to control action potential in the presence of blocker alone; the 
other trace is with blocker and VA. 9A: 5 mM 4-aminopyridine; 9B:






varying concentrations of VA (0.2-2.0 pM) for purposes of exploring a dose- 
response relationship on ionic mechanisms. At a membrane voltage (Vm) of 60 
mV, at which maximum current is usually observed in this protocol, lt0 was 
decreased significantly as VA concentration increased (Figure 10A). At VA 
concentrations above 1.2 pM, peak lt0 current traces were usually higher than
was measurable with the instrumentation available. Also at 60 mV, Iss 
increased proportionally and significantly, by over 900% when compared to 
control (Figure 10B). Because current traces for Iss were much lower than for
I t o ,  measurement was possible for VA concentrations through 2.0 pM.
Data from the isolated tissues suggested that lca may be inhibited by VA, 
and thus a number of cells were exposed to VA to confirm or reject this possible 
mechanism (n=7). The data from these experiments (Figure 1 1 ) showed that lea 
increased slightly at lower membrane voltages. The increase was not 
significant however, and is also shown to be slightly less at higher Vm’s.
Effects of blocking agents on isolated currents. As shown in other studies 
(Castle and Slawsky 1992), 1 mM 4-AP nearly completely blocked control lt0 
(Figure 12A). Yet, when VA with 1 mM 4-AP was added to the cell, no similar 
block of lto was observed, and significant increase in lto was observed (Figure 
13A). Representative current traces illustrating this effect are shown in Figure 
1 2 . 4-AP completely blocked lt0 and reduced Iss in the control cell (middle 
panel), but didn’t block the outward currents when VA was present (lower 
panel). This coincides with what was seen in Figure 13B, where Iss was 
similarly blocked with 4-AP alone, yet with VA and 4-AP, no such block was 
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FIGURE 10. VA dose- response curves for lt0 (1 0 A) and Iss (10 B). *=p<0.05,
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FIGURE 11. Current-voltage relationship for lea before and after treatment with 
1 pM VA.
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Control (EtOH) w/o 4-AP
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1000 pA  
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FIGURE 12. Current traces of a control cell with and without 4-AP, and of the 
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FIGURE 13. Effect of 4-AP on lt0 in cells with and without VA (13A), and on 
Iss (13B).
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presence of VA (Figure 13B).
When 100 nM glibenclamide was present with VA (Figure 14), l&s was
significantly and completely blocked when compared to the cells with VA alone. 
Control cells with glibenclamide had higher Iss than cells with VA and 
glibenclamide at all voltages tested.
Vulpinic Acid w /o Glibenclamide  
Vulpinic Acid with Glibenclamide  













60 804020-60 -40 0-20
V m(mV)
FIGURE 14. Effect of glibenclamide on Iss in the presence of VA 
and on control cells. *=p<0.05.
D IS C U S S IO N
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Secondary metabolites from lichens may have significant effects on the 
electrical behavior of cardiac cells of mammalian hearts. Compounds from 
various lichen metabolic pathways were tested on rat ventricular muscle and 
isolated cardiac myocytes. Some pathways represented were the shikimic acid 
pathway (vulpinic acid) and the acetate-poiymalonate pathway (p-depsides and 
depsidones such as atranorin and stictic acid respectively, and the 
dibenzofuran derivative usnic acid), as well as additional compounds from 
acetone-solubolized extractions. The parameters affected the most by these 
compounds were the action potential duration at 50% and 90% of 
repolarization, which were both shortened significantly with VA and UA and 
extracts containing VA from Letharia vulpina and UA from Cladina subtenuis.
The heart’s plasma membrane contains channels that influence the 
repolarization and the duration of the action potential (Katz 1992). The 
pertinent channels in the rat are unique in that they can be divided into an early 
phase with brief duration and a later phase which has a longer duration (Nobe 
et al. 1990). A decrease in APD50 (the early phase), suggests an effect on lt0~
an outward K+ channel, lto significantly contributes to the repolarization phase
of the action potential and is voltage sensitive (-40 to +60 mV); if it is large (as in 
rat myocytes), it leads to short repolarization times. Parallel to this and 
operating more or less simultaneously is an opposing inward current carried by 
Ca2+ (|Ca). The Ca2+ current determines APD and refractory period, and also is
an important determinant of the plateau phase, although in rat myocytes it is 
thought to have a lesser influence than in some other species, eg. guinea pig.
26
The effects on APDgo (the later phase) are usually attributed to an inward
current arising from electrogenic Na+/Ca2+ exchange (lNa/Ca) which is itself
secondarily activated by lca and the subsequent release of Ca2+ from the 
sarcoplasmic reticulum (Nobe et al. 1990) which initiates cardiac contraction. 
When ryanodine, a blocker of Ca2+ release from sarcoplasmic reticulum, is 
present, APDgo is shortened similarly to that seen in this study (Nobe et al.
1990). Also independent of this is an outward K+ channel, called the delayed 
rectifier ( Ik ) or the potassium steady state current (Iss), which is responsible for 
repolarization of the cardiac cell back to the resting membrane potential (Apkon 
& Nerbonne, 1991). Ik is activated at voltages positive to -45 mV and 
inactivates slowly. As Ik may contribute to lss, in this experiment Iss will be used, 
in synonymy with Ik- Since both APD50 and APDg0 are shortened significantly, 
these data suggest that either lt0 is enhanced and /or lca is decreased. Further, 
it may be proposed that Ik was increased or the Na+/Ca2+ exhange decreased
due to block of Ca2+ release from sarcoplasmic reticulum.
The effects of blockers may indicate some of the possible mechanisms 
responsible for the effects of purified compounds and extracts. The fact that 4- 
AP did not prevent further shortening of APD50 when VA was applied, suggests 
that lto is not a likely target of these compounds. The prevention of further 
shortening of APD50 and reduced shortening of APDgo when C0 CI2 is used with 
VA indicates that lca is influenced by the extracts and purified compounds. It is 
possible VA may itself be a blocker of the Ca2+ channel and act similarly to 
cobalt chloride, which by itself led to a marked shortening of action potential 
duration. These data also suggest that lca plays an important role in
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determining the duration of the rat action potential at 50% and 90% of 
repolarization.
The results observed when Bay K 8644 was used in the presence of VA 
indicates that these compounds may modify or antagonize the gating 
characteristics or activation of C a 2 +  channels, perhaps related to voltage 
sensing. When tissues were treated with VA, washed out, then followed by 
application of SA, a large shortening of both APD5o and APDgo was seen, thus 
providing evidence that these compounds may cause sensitization or 
modification of C a 2 +  channels.
The possibility exists that these compounds may act as metabolic 
inhibitors. As stated above, the work of Soderberg (1953) suggests that these 
products may have effects similar to dinitrophenols. The fact that the Letharia 
extract was often not reversible and eventually toxic would support this 
possibility. A recent paper by Ogbaghebriel and Shrier (1994) utilized 2,4- 
dinitrophenol and cyanide, both inhibitors of oxidative phosphorylation, to 
abolish lt0. They also discovered that another K+ channel controlled by 
intracellular ATP (K a tp )  is induced in rabbit cardiomyocytes in the presence of 
these metabolic inhibitors, resulting in a shortening of APD. When intracellular 
ATP concentration is reduced below normal levels in the presence of cyanide, 
action potential shortening also occurs due to activation of K a t p  (Nichols et al.
1991). During blockade of these channels by sulfonylurea agents like 
glibenclamide or tolbutamide, lt0 is partially restored and APD is prolonged 
(Faivre & Findlay 1989; Ogbaghebriel and Shrier 1994). Other compounds, 
such as pinacidil, nicorandil, or cromakalin, have been shown to activate these 
currents directly (Arena & Kass 1989), or by regulation of GTP-binding proteins
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(G proteins) (Kirsch et al. 1990). The possibility of pinacidil-like activities is 
attractive because these compounds may be medically useful as 
antihypertensive agents and vasodilators. The effect seen in these experiments 
when glibenclamide was used would suggest that lichen metabolites may 
activate the ATP-sensitive K+ currents either directly or by lowering intracellular 
ATP.
Analysis of patch clamp data confirms and further illuminates some of the 
previously discussed mechanisms. That lt0 is not involved is suggested by the 
tissue electrophysiology data when the effect of VA was not blocked by 4-AP 
and further supported by patch-clamp data which shows that lt0 is significantly 
decreased as VA concentration is increased (Figure 10A). When 4-AP is used 
with controls, as shown in Figures 12A and 13 (middle panel), lt0 is blocked 
nearly completely, showing the expected effectiveness of 4-AP as a blocker of 
lt0. The appearance of an increase in lt0 when VA is added (Figure 12) relates
to current overlap, ie. some other outward K+ current must be activated at these 
same membrane voltages. Figure 13 (lower panel) illustrates that even with 4- 
AP, VA caused large currents to develop.
Figure 13 (middle panel) shows that Iss is also largely blocked by 4-AP, 
yet Fig. 12B shows a large Iss produced by VA even in the presence of 4-AP 
and which is concentration related (Figure 10B). This overlapping current then, 
obscures the true lt0 and Iss. making them appear that they are increasing 
when in fact they are not.
The actual current being activated by VA, however, can be blocked by 
glibenclamide, as illustrated in Figure 14. When K a tp  is blocked by glibencla­
mide, Is s  is reduced significantly. Thus, VA may activate K a tp  either directly or
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by reducing intracellular ATP. This is supported by the tissue electrophysiology 
phase, which showed that the ADP was restored to normal or even longer 
duration by the addition of glibenclamide (Figure 9D).
Tissue evidence suggested that lca may.be influenced, and based on the 
effects of VA on APD one could surmise that lca was possibly being decreased. 
The analysis of lca patch-clamp data,, however, suggests this is not the case 
(Figure 11). Rather, lca was increased by VA, albeit not significantly. The 
hypothetical involvement of lca was again probably caused by the huge 
influence upon K a t p  which would lead to similar effects one would normally see 
from decreased lca- Since K a tp  is not the one usually expected to be involved 
in development of these effects, a person usually begins developing 
hypotheses from the most usual and obvious causes, which in this case was lt0, 
lK, and/or lCa-
The lichen species used to obtain the extracts, and the purified forms 
themselves, were chosen more or less randomly- primarily because of their 
availability or abundance. That two out of 4 purified lichen compounds caused 
significant shortening of the APD50 and APDgo, and that one of those two had 
further significant effects on RMP, amplitude, and Vmax, would indicate that 
certain lichen compounds effect a high degree of activity at the cellular level. 
This activity, eg. toxicity, may suggest a possible evolutionary role for these 
compounds, perhaps as pesticides or insecticides. Along with the known 
antibacterial properties some of these secondary metabolites possess, these 
additional activities may confer protection from consumption or invasion by 
small organisms. It is likely that many more of these compounds, which number 
at least 150 in several biochemical classes (Hale 1983), may have similar
30
dramatic effects at the cellular levels, and may have value as research tools, 
pharmacological application, or perhaps even medicinal uses.
The possible influence of lichen metabolites upon ion channels, 
particularly on Ca2+ and K+ channels, has been studied and such informaiton 
may provide clues to some useful applications for these lichen compounds.
The significance of these effects is best realized when one considers the role 
and importance that these channels play in many biological responses and 
physiological functions. The Ca2+ channel is an ubiquitous component of 
cellular function which is essential for many biological responses. It is found in 
nerve, muscle, and cardiac cells from Paramecium to humans. Secretions, 
synapatic activity, excitability, and particularly contraction in cardiac muscle are 
some functions at least partically dependent upon these channels. The 
potassium channels are also responsible for a number of actions. It0 and Ik 
contribute to the repolarization phase of the cardiac action potential and 
.determines repolarization of the action potential in squid axon, skeletal and 
heart muscle, and slow wave activity (smooth muscle). K a tp  is activated by 
metabolic inhibitors and is responsive to lowered intracellular ATP levels, 
hypoxia/anoxia, reduced intracellular pH, and lactate, and may protect against 
ischemia in ventricular muscle, skeletal muscle, and in pancreatic cells, may be 
sensitive to lowered glucose levels and link calcium and insulin secretion by 
maintaining depolarized voltages.
The following points summarize the effects of lichen metabolites on rat 
heart muscle tissue and isolated myocytes:
1. Extracts from Letharia vulpina and Cladina subtenuis cause significant 
shortening of action potential duration at 50 and 90% of re polarization
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(APD50 and APD90).
2. Letharia vulpina also causes significant modifications to resting membrane 
potential (RMP), amplitude (Ampl), and maximum rate of rise of the action 
potential upstroke (Vmax)-
3. Usnic acid and vulpinic acid cause significant shortening of APD50 and 
APD9 0 .
4. Transient outward current (lt0) is decreased with increasing concentrations of 
vulpinic acid.
5. A significant increase in an outward steady state potassium current is elicited 
by vulpinic acid. The increased steady state current is not sensitive to 4- 
aminopyridine, suggesting it is not lt0.
6 . An inward calcium current is consistently but not signficantly increased by 
vulpinic acid.
7. The steady state potassium current is reduced significantly by glibenclamide, 
suggesting it is an ATP-sensitive potassuim current (K a tp )>  and may be 
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